The Effect of Growth Hormone Therapy on Cardiac Outcomes in Noonan Syndrome: Long Term Follow-up Results
Sirmen Kizilcan CetinMehmet Gökhan RamoğluZeynep ŞiklarElif ÖzsuZehra AycanHasan Ercan TutarMerih BerberoğluPublished in: Journal of clinical research in pediatric endocrinology (2022)
In this cohort, there was no change in ECHO parameters on rGH and during follow-up. These results suggest that rGH is safe in NS patients with cardiac pathology under close follow-up.